Trial Profile
A Long-Term, Open-Label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Acotiamide (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- 18 Oct 2008 New trial record.